(1)
Joysoual, M. R.; Ara, S.; Razzaque, S.; Islam, M. Safety of Empagliflozin As Add-on Therapy in Patients With Uncontrolled Type 2 Diabetes Mellitus. Khwaja Yunus Ali Medical College Journal 2026, 16, 119-122.